43 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
in order to leverage technology to enhance stockholder access to the Annual Meeting by enabling attendance and participation from any location. We believe … , that allow companies to distribute their proxy materials over the Internet under the “notice and access” approach. As a result, we are mailing to our
8-K
EX-10.1
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
limitation, computer equipment, laptops, monitors, software, keys and access cards, credit cards, files and any documents (including, without limitation … on the Separation Date. You further understand and agree that you have been employed in a position of confidence and trust and have had access to information
8-K
EX-10.2
fcpf4w1zls xj23ijj
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-1.1
5ezy2u jol48q
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
0223eg0 sg
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
9cxv5xmez4hjr88s
29 Jun 23
Prospectus supplement for primary offering
6:02am
S-3
d34 w1zcrits
14 Nov 22
Shelf registration
4:15pm
DEF 14A
1rjymqgz6
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
qu0l38x2bl 4z7l4d3
1 Feb 21
Automatic shelf registration
5:28pm
S-3ASR
EX-1.2
eend6wn ka
1 Feb 21
Automatic shelf registration
5:28pm